Funding for ongoing dental and craniofacial clinical trials from NIDCR.
Funder: National Institutes of Health
Due Dates: March 8, 2027 (Renewal/resubmission/revision) | July 7, 2027 (Renewal/resubmission/revision) | November 8, 2027 (Renewal/resubmission/revision) | January 6, 2028 (Closing date)
Funding Amounts: No budget cap; requests must reflect actual project needs; up to 5 years; no cost sharing required
Summary: Supports competing renewals and competitive revisions of ongoing NIDCR-supported clinical trials in dental, oral, and craniofacial health.
Key Information: Only ongoing NIDCR-supported trials qualify; each award supports a single clinical trial.
The National Institute of Dental and Craniofacial Research (NIDCR) administers this UH3 cooperative agreement to extend or modify ongoing NIDCR-supported clinical trials. Competing renewals support additional time to complete a trial or justified longer-term follow-up. Competitive revisions support compelling changes to an ongoing trial’s scope.
Eligible work includes diagnostic, prevention, management, and treatment approaches testing drugs, biologics, devices, procedures, or behavioral and social interventions for dental, oral, or craniofacial diseases and conditions. Trials may involve any testing phase of an FDA-regulated product or other stages of behavioral intervention development. NIDCR expects hypothesis-driven trials with clinically meaningful outcomes important to patients and health care providers, measurable annual milestones, and potential for high impact. NIDCR staff provide substantial scientific and operational guidance throughout the award.